Targeting ROR1 and a two-drug approach to cure CLL
Should we use the word 'cure' in CLL?
Integrating molecular variables into prognostic models for patients with MPNs
Standardising CLL patient stratification globally
How important is understanding the tumour microenvironment in treating CLL?